GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 60.85
+0.57 (0.95%)
At close: Mar 8, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 5.08 billion as of March 9, 2026. Its market cap has increased by 60.09% in one year.
Market Cap
5.08B
Enterprise Value
6.00B
Revenue
3.74B
Ranking
n/a
PE Ratio
51.94
Stock Price
60.85
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 5.08B, an increase of 792.41%. That is a compound annual growth rate of 11.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition